Julie VanOrsdel Daves, MSHS

Senior Director, Clinical Outsourcing & Operations at miRagen Therapeutics, Inc.

Julie Daves is Senior Director of Clinical Operations and Outsourcing at miRagen Therapeutics, Inc.  She has almost 20 years of experience in both the operational and outsourcing aspects of clinical development.  Julie has an MSHS from The George Washington University School of Medicine & Health Sciences.  She began her career as a hands-on CRA and has worked operationally managing studies and programs in almost 40 countries in roles at CROs and pharmaceutical companies.  In the last 10 years, she has been a leader focused on building strong partnerships between vendors and sponsors, and has been responsible for contractual and quality oversight leadership for hundreds of vendors in widely varying therapeutic areas, including oncology.  She has also consulted for small biotech and big pharma, forming and managing vendor-pharma contracts with values upwards of $100M USD.  Julie is passionate about optimizing vendor-sponsor relationships, because by doing so, drugs ultimately get to the patients who need them faster and less expensively

My Sessions

Innovation in Study Start-Up – Panel Discussion

Main Session Room

In this panel discussion, leading clinical operations/ supply industry experts will share real-life examples of ways their organizations are innovating within the study start-up stage of clinical trials and thus accelerating the entire clinical development process to get needed and life-saving medicine to patients sooner with greater efficiencies. This panel discussion is sponsored by TrialCard.

Clinical Site Contracts, Budgets and Payments

Reducing and Controlling Clinical Trial Costs – Panel

Main Session Room